Preethi Srikanthan, MD, MS is an attending Endocrinologist and Professor of Medicine at the David Geffen School of Medicine at UCLA. She is the clinical director of research programs at the UCLA Research center at Alhambra where she oversees several large multicenter epidemiologic studies.
Dr. Srikanthan is an active investigator with Multiethnic Study of Atherosclerosis, a multicenter study evaluating modern risk factors impacting the progression from subclinical to clinical atherosclerosis. Further, her important work as a part of the Diabetes Prevention Program Outcome Study (DPPOS), has proven that even 10 years after a period of active lifestyle change or metformin use, these treatments can still delay type 2 diabetes and cardiovascular risk factors by as much as 34% in a group of obese Americans, at risk for diabetes. Further, Dr. Srikanthan's epidemiologic studies evaluating the metabolic and cardiovascular import of changes in body composition (specifically increased muscle mass) have lead to multiple highly cited manuscripts which have had significant public health impact.
Dr. Srikanthan's clinical interests include treating and preventing obesity and type 2 diabetes in addition to managing thyroid autoimmune disease/nodules and thyroid cancer.
Dr. Srikanthan received her undergraduate training and medical degree at the University of Melbourne, Australia. She completed postgraduate training in internal medicine at both the University of California Los Angeles and the University of Iowa and later a fellowship in endocrinology and a Masters in Clinical Research at the University of California, Los Angeles. She is also certified by the American Board of Internal Medicine in Endocrinology.
Medical Board Certification
- Body Composition
- Brown Adipose tissue
- Type 2 diabetes and cardiovascular outcomes
- Cardiovascular Prevention
Dr Srikanthan's research involves both epidemiologic and clinical translational work, focusing on obesity, body composition and cardiovascular disease. While she has been pivotal in the epidemiologic research done by the Multiethnic study of Atherosclerosis ( MESA) and the Diabetes Prevention Program Outcomes Study (DPPOS), she has several clinical translational projects evaluating the metabolic role of brown adipose tissue.